{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:12:01Z","timestamp":1792177921795,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.omtm.2020.03.005","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T06:16:53Z","timestamp":1584080213000},"page":"491-496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Enhanced Production of Herpes Simplex Virus 1 Amplicon Vectors by Gene Modification and Optimization of Packaging Cell Growth Medium"],"prefix":"10.1016","volume":"17","author":[{"given":"Iv\u00e1n","family":"Fern\u00e1ndez-Fr\u00edas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"P\u00e9rez-Luz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"D\u00edaz-Nido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.03.005_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.gene.2013.03.137","article-title":"History of gene therapy","volume":"525","author":"Wirth","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.omtm.2020.03.005_bib2","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1089\/hum.2017.160","article-title":"Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future","volume":"28","author":"Piguet","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.03.005_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.03.005_bib4","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.03.005_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/rmv.1872","article-title":"Membrane dynamics associated with viral infection","volume":"26","author":"de Armas-Rillo","year":"2016","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.omtm.2020.03.005_bib6","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1128\/JVI.00443-10","article-title":"Virus cell-to-cell transmission","volume":"84","author":"Mothes","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.03.005_bib7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1134\/S0006297916070063","article-title":"Viral Vectors for Gene Therapy: Current State and Clinical Perspectives","volume":"81","author":"Lukashev","year":"2016","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.omtm.2020.03.005_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-60327-369-5_8","article-title":"Strategies for designing transgenic DNA constructs","volume":"1027","author":"Liu","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2020.03.005_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygeno.2015.05.006","article-title":"Delivery of the 135 kb human frataxin genomic DNA locus gives rise to different frataxin isoforms","volume":"106","author":"P\u00e9rez-Luz","year":"2015","journal-title":"Genomics"},{"key":"10.1016\/j.omtm.2020.03.005_bib10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s11248-011-9561-3","article-title":"The creation of transgenic pigs expressing human proteins using BAC-derived, full-length genes and intracytoplasmic sperm injection-mediated gene transfer","volume":"21","author":"Watanabe","year":"2012","journal-title":"Transgenic Res."},{"key":"10.1016\/j.omtm.2020.03.005_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/dvg.20411","article-title":"Robust acinar cell transgene expression of CreErT via BAC recombineering","volume":"46","author":"Ji","year":"2008","journal-title":"Genesis"},{"key":"10.1016\/j.omtm.2020.03.005_bib12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ygeno.2007.07.005","article-title":"Factor VIII mRNA expression from a BAC carrying the intact locus made by homologous recombination","volume":"90","author":"P\u00e9rez-Luz","year":"2007","journal-title":"Genomics"},{"key":"10.1016\/j.omtm.2020.03.005_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00335-012-9436-9","article-title":"Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1)","volume":"24","author":"Xing","year":"2013","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.omtm.2020.03.005_bib14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2174\/156652321306140103224550","article-title":"Biosafety of gene therapy vectors derived from herpes simplex virus type 1","volume":"13","author":"Lim","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtm.2020.03.005_bib15","first-page":"169","article-title":"HSV-1-derived helper-independent defective vectors, replicating vectors and amplicon vectors, for the treatment of brain diseases","volume":"13","author":"Marconi","year":"2010","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.omtm.2020.03.005_bib16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ymthe.2004.06.641","article-title":"Update on herpesvirus amplicon vectors","volume":"10","author":"Oehmig","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.005_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0092-8674(82)90035-6","article-title":"The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector","volume":"30","author":"Spaete","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2020.03.005_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1006\/mthe.2001.0294","article-title":"Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome","volume":"3","author":"Saeki","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.005_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0958-1669(02)00359-2","article-title":"Replication-defective genomic herpes simplex vectors: design and production","volume":"13","author":"Burton","year":"2002","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.omtm.2020.03.005_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/bit.26461","article-title":"Advancements in the design and scalable production of viral gene transfer vectors","volume":"115","author":"Sharon","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omtm.2020.03.005_bib21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/bit.10162","article-title":"Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors","volume":"77","author":"Ozuer","year":"2002","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omtm.2020.03.005_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.gt.3301340","article-title":"Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers","volume":"8","author":"Bowers","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.03.005_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ymben.2013.10.001","article-title":"Metabolic pathways recruited in the production of a recombinant enveloped virus: mining targets for process and cell engineering","volume":"20","author":"Rodrigues","year":"2013","journal-title":"Metab. Eng."},{"key":"10.1016\/j.omtm.2020.03.005_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymben.2009.09.003","article-title":"Viral vectors for the treatment of alcoholism: use of metabolic flux analysis for cell cultivation and vector production","volume":"12","author":"Martinez","year":"2010","journal-title":"Metab. Eng."},{"key":"10.1016\/j.omtm.2020.03.005_bib25","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1016\/j.vaccine.2014.10.067","article-title":"Rational design of medium supplementation strategy for improved influenza viruses production based on analyzing nutritional requirements of MDCK Cells","volume":"32","author":"Huang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.omtm.2020.03.005_bib26","first-page":"133","article-title":"Efficiency of lipofection of adherent cells is limited by apoptosis","volume":"40","author":"Bednarek","year":"2002","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.omtm.2020.03.005_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrc.2015.17","article-title":"Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies","volume":"16","author":"Delbridge","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omtm.2020.03.005_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10616-010-9274-0","article-title":"Cell death in mammalian cell culture: molecular mechanisms and cell line engineering strategies","volume":"62","author":"Krampe","year":"2010","journal-title":"Cytotechnology"},{"key":"10.1016\/j.omtm.2020.03.005_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ymben.2014.06.010","article-title":"The impact of anti-apoptotic gene Bcl-2\u0394 expression on CHO central metabolism","volume":"25","author":"Templeton","year":"2014","journal-title":"Metab. Eng."},{"key":"10.1016\/j.omtm.2020.03.005_bib30","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/13543776.2016.1211640","article-title":"Cancer suicide gene therapy: a patent review","volume":"26","author":"Navarro","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.omtm.2020.03.005_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1517\/14712598.2016.1114096","article-title":"Gene therapy for neurological disorders","volume":"16","author":"Choong","year":"2016","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omtm.2020.03.005_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/humc.2013.119","article-title":"The committee for advanced therapies\u2019 of the European Medicines Agency reflection paper on management of clinical risks deriving from insertional mutagenesis","volume":"24","author":"Aiuti","year":"2013","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omtm.2020.03.005_bib33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s11262-017-1482-7","article-title":"Herpesviral vectors and their application in oncolytic therapy, vaccination, and gene transfer","volume":"53","author":"Bailer","year":"2017","journal-title":"Virus Genes"},{"key":"10.1016\/j.omtm.2020.03.005_bib34","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/bit.22439","article-title":"The effect of Bcl-2, YAMA, and XIAP over-expression on apoptosis and adenovirus production in HEK293 cell line","volume":"104","author":"Sandhu","year":"2009","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omtm.2020.03.005_bib35","doi-asserted-by":"crossref","first-page":"e0140597","DOI":"10.1371\/journal.pone.0140597","article-title":"Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody","volume":"10","author":"Torkashvand","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.03.005_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jbiotec.2016.06.029","article-title":"Targeted supplementation design for improved production and quality of enveloped viral particles in insect cell-baculovirus expression system","volume":"233","author":"Monteiro","year":"2016","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.omtm.2020.03.005_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/sj.mt.6300021","article-title":"Infectious delivery and expression of a 135 kb human FRDA genomic DNA locus complements Friedreich\u2019s ataxia deficiency in human cells","volume":"15","author":"Gomez-Sebastian","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.005_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0091-679X(08)61930-5","article-title":"Calcium, free radicals, and excitotoxic neuronal death in primary cell culture","volume":"46","author":"Mattson","year":"1995","journal-title":"Methods Cell Biol."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120300358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120300358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:52:47Z","timestamp":1778867567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120300358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":38,"alternative-id":["S2329050120300358"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.03.005","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced Production of Herpes Simplex Virus 1 Amplicon Vectors by Gene Modification and Optimization of Packaging Cell Growth Medium","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}